1,5-anhydro-D-fructose: A natural antibiotic that inhibits the growth of gram-positive bacteria and microbial biofilm formation to prevent nosocomial infection

Experimental and Therapeutic Medicine

Volumn 2, Issue 4, 2011, Pages 625-628

  Meng, Xiaojie ^a   Kawahara, Ko Ichi ^a   Miyanohara, Hiroaki ^b   Yoshimoto, Yasushi ^c   Yoshinaga, Kazuhiro ^c   Noma, Satoshi ^a   Kikuchi, Kiyoshi ^a,g   Morimoto, Yoko ^d   Ito, Takashi ^a   Oyama, Yoko ^a   Yoshinaga, Narimasa ^a   Shrestha, Binita ^a   Chandan, Binita ^a   Mera, Kentaro ^d   Tada, Ko Ichi ^d   Miura, Naoki ^e   Ono, Yoshiko ^f   Takenouchi, Kazunori ^a   Maenosono, Ryuichi ^a,b   Nagasato, Tomoka ^a   Hashiguchi, Teruto ^a   Maruyama, Ikuro ^d   more..

^a Advanced Therapeutics ^*  (Japan)

^b KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^c Nihon Starch Co Ltd   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

^g Yame General Hospital   (Japan)

Author keywords

1,5 anhydro d fructose; Biofilm; Natural antibiotic

Indexed keywords

1,5 ANHYDROFRUCTOSE; FRUCTOSE; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; ARTICLE; BIOFILM; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG EFFICACY; GRAM POSITIVE INFECTION; HOSPITAL INFECTION; INFECTION PREVENTION; NONHUMAN; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 79958066852     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.245     Document Type: Article

References (18)

1. Coast J, Smith RD and Millar MR: Superbugs: should antimicrobial resistance be included as a cost in economic evaluation? Health Econ 5: 217-226, 1996.
2. Lewis K: Riddle of biofilm resistance. Antimicrob Agents Chemother 45: 999-1007, 2001.
3. Fux CA, Stoodley P, Hall-Stoodley L and Costerton JW: Bacterial bio films: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther 1: 667-683, 2003.
4. Schachter B: Slimy business - the biotechnology of biofilms. Nat Biotechnol 21: 361-365, 2003.
5. Yu S, Bojsen K, Svensson B and Marcussen J: α-l,4-Glucan lyases producing 1,5-anhydro-D-fructose from starch and glycogen have sequence similarity to α-glucosidases. Biochim Biophys Acta 1433: 1-15, 1999.
6. Baute M-A, Baute R and Deffeux G: Fungal enzymic activity degrading 1,4-a-D-glucans to 1,5,-D-anhydrofructose. Phytochemistry 27: 3401-3403, 1988.
7. Broberg A, Kenne L and Pedersen M: Analysis of 1,5-anhydro-D-fructose, microthecin, and 4-deoxy-glycero-2,3-diulose in algae using gas chromatography-mass spectrometry in selected ion monitoring mode. Anal Biochem 268: 35-42, 1999.
8. Shiga Y, Kametani S, Kadokura T and Akanuma H: 1, 5 - Anhydroglucitol promotes glycogenolysis in Escherich ia coli. J Biochem 125: 166-172, 1999.
9. Kametani S, Shiga Y and Akanuma H: Hepatic production of 1,5-anhydrofructose and 1,5-anhydroglucitol in rat by the third glycogenolytic pathway. Eur J Biochem 242: 832-838, 1996.
10. Yu S and Fiskesund R: The anhydrofructose pathway and its possible role in stress response and signaling. Biochim Biophys Acta 1760: 1314-1322, 2006.
11. Yamaji K, Sarker K P, Maruyama I and Hizukuri S: Antioxidant effects of 1,5-anhydro-D-fructose, a new natural sugar, in vitro. Planta Med 68: 16-19, 2002.
12. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM and Beachey EH: Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adhesion of staphylococci to medical devices. J Clin Microbiol 22: 996-1006, 1985.
13. Mango K, Nishi J, Wakimoto N, et al: Biofilm formation by and accessory gene regulator typing of methicillin-resistant Staphylococcus aureus strains recovered from patients with nosocomial infections. Infect Control Hosp Epidemiol 27: 188-190, 2006.
14. Isenberg HD: Clinical Microbiology Procedures Handbook. ASM Press, Washington, DC, pp1.5.1-1.5.18, 2004.
15. Djordjevic D, Wiedmann M and McLandsborough LA: Microtiter plate assay for assessment of Listeria monocytogenes bioflm formation. Appl Environ Microbiol 68: 2950-2958, 2002.
16. Darmstadt GL, Nawshad Uddin Ahmed AS, Saha SK, et al: Infection control practices reduce nosocomial infections and mortality in preterm infants in Bangladesh. J Perinatol 25: 331-335, 2005.
17. Meng X, Kawahara K, Nawa Y, et al: 1,5-Anhydro-D-fructose attenuates lipopolysaccharide-induced cytokine release via suppression of NF-kappaB p65 phosphorylation. Biochem Biophys Res Commun 380: 343-348, 2009.
18. Meng X, Kawahara K, Matsushita K, et al: Attenuation of LPS-induced iNOS expression by 1,5-anhydro-D-fructose. Biochem Biophys Res Commun 387: 42-46, 2009.